17 alpha-hydroxylase deficiency differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:
==Differentiating 17 alpha-hydroxylase deficiency from other Diseases==
==Differentiating 17 alpha-hydroxylase deficiency from other Diseases==
17 alpha-hydroxylase deficiency must be differentiated from diseases with [[undervirilization]] in males. These diseases include androgen insensitivity syndrome,  
17 alpha-hydroxylase deficiency must be differentiated from diseases with [[undervirilization]] in males. These diseases include androgen insensitivity syndrome,  


{| class="wikitable"  
{| class="wikitable"  
Line 26: Line 24:
|-
|-
|Disorders with abnormal testicular activity 
|Disorders with abnormal testicular activity 
|
|Gonadal dysgenesis
|
|
|-
|-

Revision as of 15:35, 4 August 2017

Congenital adrenal hyperplasia main page

17 alpha-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17 alpha-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17 alpha-hydroxylase deficiency differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17 alpha-hydroxylase deficiency differential diagnosis

CDC on 17 alpha-hydroxylase deficiency differential diagnosis

17 alpha-hydroxylase deficiency differential diagnosis in the news

Blogs on 17 alpha-hydroxylase deficiency differential diagnosis

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

Risk calculators and risk factors for 17 alpha-hydroxylase deficiency differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency must be differentiated from other diseases that cause similar clinical features, such as 5-alpha-reductase deficiency and hypogonadism.[1]

Differentiating 17 alpha-hydroxylase deficiency from other Diseases

17 alpha-hydroxylase deficiency must be differentiated from diseases with undervirilization in males. These diseases include androgen insensitivity syndrome,

Androgen insensitivity syndrome , cell 1 , cell 2 row 1, cell 3
3-beta-hydroxysteroid dehydrogenase type 2 deficiency , cell 1 row 2, cell 2 row 2, cell 3
Disorders with abnormal testicular activity  Gonadal dysgenesis

References

  1. Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016